Intraperitoneal administration of the angiogenesis inhibitor thalidomide does not impair anastomotic healing following large bowel resection in a rabbit model

World Journal of Surgery

Volumn 27, Issue 10, 2003, Pages 1119-1123

  Mall, Julian W ^a   Schwenk, Wolfgang ^a   Philipp, Andreas W ^a   Büttemeyer, Rolf ^a   Pollmann, Christian ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; CD31 ANTIGEN; MONOCLONAL ANTIBODY KI 67; THALIDOMIDE;

ANASTOMOSIS; ANGIOGENESIS; ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CECUM; CELL PROLIFERATION; COLON; COLON ANASTOMOSIS; COLON RESECTION; CONTROLLED STUDY; DRUG EFFECT; END TO END ANASTOMOSIS; FEMALE; IMMUNOHISTOCHEMISTRY; INTESTINE PRESSURE; INTRAPERITONEAL DRUG ADMINISTRATION; LEUKOCYTE COUNT; NONHUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTEIN EXPRESSION; RABBIT; TENSILE STRENGTH; WOUND HEALING;

ANASTOMOSIS, SURGICAL; ANGIOGENESIS INHIBITORS; ANIMALS; CECUM; COLON; FEMALE; INJECTIONS, INTRAPERITONEAL; MODELS, ANIMAL; RABBITS; TENSILE STRENGTH; THALIDOMIDE; WOUND HEALING;

EID: 0141888986     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-003-7009-5     Document Type: Article

References (26)

1. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1995;1:27-31
2. Weidner N, Sample JP, Welch WR, et al. Tumor angiogenesis and metastasis in invasive breast carcinoma. N. Engl. J. Med. 1991;324:1-8
3. Weidner N, Carroll PR, Flax J, et al. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am. J. Pathol. 1993;143:401-409
4. Saclarides TJ, Speziale NJ, Drab E, et al. Tumor angiogenesis and rectal carcinoma. Dis. Colon Rectum 1994;37:921-926
5. Machianini P, Fontanini G, Hardin JM, et al. Relation of neovascularization to metastasis of non-small cell lung cancer. Lancet 1992;340:45-46
6. Singhal S, Mehta J, Desikan R, et al. Antitumor activity of thalidomide in refractory multiple myeloma. N. Engl. J. Med. 1999;341:1565-1571
7. Fine HA. Novel biologic therapies for malignant gliomas. Antiangiogenesis, immunotherapy and gene therapy. Neurol. Clin. 1995;13:827-846
8. Sheskin J. Thalidomide in the treatment of lepra reactions. Clin. Pharmacol. Ther. 1965;6:303-306
9. Hellmann K, Duke DI, Tucker DF. Prolongation of skin homograft survival by thalidomide. Br. Med. J. 1965;18:687-689
10. Turk JL, Hellmann K, Duke DI. Effect of thalidomide on the immunological response in local lymph nodes after a skin homograft. Lancet 1966;7447:1134-1136
11. Stephens TD, Bunde CJW, Fillmore BJ. Mechanism of action in thalidomide teratogenesis. Biochem. Pharm. 2000;59:1489-1499
12. Hendriks JMH, Hubens G, Wuyts FL, et al. Experimental study of intraperitoneal suramin on the healing of colonic anastomoses. Br. J. Surg. 1999;86:1171-1175
13. Fielding LP. Anastomotic integrity after operation for large bowel cancer: a multicentre study. Br. Med. J. 1980;281:746
14. Verheul HMW, Panigrahy D, Yuan J. Combination oral antiangiogenic therapy with thalidomide and sulindac inhibits tumour growth in rabbits. Br. J. Cancer 1999;79:114-118
15. Holmgren L, O'Reilly MS, Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat. Med. 1995;1:149-153
16. Myers JA, Mehta P, Hunter AW, et al. Automated double-label immunohistochemistry. J. Surg. Pathol. 1995;1:105
17. Fielding LP. Anastomotic integrity after operation for large bowel cancer: A multicentre study. Br. Med. J. 1980;281:746
18. Irvin TT, Göligher JC. Aetiology of disruption of intestinal anastomoses. Br. J. Surg. 1973;60:461-464
19. Wise L, McAlister W, Stein T, et al. Studies on the healing of anastomoses of small and large bowel. Surg. Gynecol. Obstet. 1975;141:190-194
20. Nahai F, Lamb JM, Havican RG, et al. Factors involved in disruption of intestinal anastomoses. Am. Surg. 1977;43:45-51
21. Zwingenberger K, Wendt S. Immunomodulation by thalidomide: systematic review of the literature and of unpublished observations. J. Inflamm. 1996;46:177-211
22. Brasken P, Lehto M, Renvall S. Changes in the connective tissue composition of the submucosal layer of colonic anastomosis. Acta Chir. Scand. 1989;155:413-419
23. Lindner J. Morphology and biochemistry of wound healing. Langenbecks Arch. Chir. 1982;358:153-160
24. Brasken P, Lehto M, Renvall S. Fibronectin, laminin and collagen types I, III, IV and V in the healing of rat colonic anastomosis. Ann. Chir. Gynaecol. 1990;79:56-61
25. D'Amato RJ, Loughnan MS, Flynn E, et al. Thalidomide is an inhibitor of angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 1994;91:4082-4085
26. Geist C, Wöhrmann J, Schneider K, et al. Effects of thalidomide on the local Schwartzman reaction in mice and rabbits. FEMS Immunol. Med. Microbiol. 1995;12:165-174